BACKGROUND: Geographic and doctor-to-doctor variations in care are a focus of quality and safety efforts in medicine. This study addresses factors associated with variation in the rate of operative treatment of de Quervain tendinopathy. METHODS: We used a database including all patient encounters at 2 large medical centers, to study the experience of 10 hand surgeons and 1 physiatrist working in a hand surgery office in the treatment of 2,513 patients with de Quervain tendinopathy over a 12-year period. Survival analysis using the Kaplan-Meier method was used to compare surgery rates and time to surgery. Cox multivariable regression analysis was applied to identify factors associated with operative treatment. RESULTS: One hundred ninety nine (7.9%) patients had surgery. The odds of operative treatment were 1.7 times greater after corticosteroid injection and varied more than 10-fold among providers. There was substantial variation in the overall rate of surgery by provider. Corticosteroid injection delayed surgery slightly, but was associated with a higher rate of surgery. CONCLUSION: Providers have substantial influence on treatment of de Quervain tendinopathy. The use of decision aids and other methods that help involve the patient in decision-making merit investigation as interventions to help reduce doctor-to-doctor variation.
BACKGROUND: Geographic and doctor-to-doctor variations in care are a focus of quality and safety efforts in medicine. This study addresses factors associated with variation in the rate of operative treatment of de Quervain tendinopathy. METHODS: We used a database including all patient encounters at 2 large medical centers, to study the experience of 10 hand surgeons and 1 physiatrist working in a hand surgery office in the treatment of 2,513 patients with de Quervain tendinopathy over a 12-year period. Survival analysis using the Kaplan-Meier method was used to compare surgery rates and time to surgery. Cox multivariable regression analysis was applied to identify factors associated with operative treatment. RESULTS: One hundred ninety nine (7.9%) patients had surgery. The odds of operative treatment were 1.7 times greater after corticosteroid injection and varied more than 10-fold among providers. There was substantial variation in the overall rate of surgery by provider. Corticosteroid injection delayed surgery slightly, but was associated with a higher rate of surgery. CONCLUSION: Providers have substantial influence on treatment of de Quervain tendinopathy. The use of decision aids and other methods that help involve the patient in decision-making merit investigation as interventions to help reduce doctor-to-doctor variation.
Authors: James N Weinstein; Jon D Lurie; Patrick R Olson; Kristen K Bronner; Elliott S Fisher Journal: Spine (Phila Pa 1976) Date: 2006-11-01 Impact factor: 3.468
Authors: Audrey Petit Le Manac'h; Yves Roquelaure; Catherine Ha; Julie Bodin; Geraldine Meyer; Frederic Bigot; Martin Veaudor; Alexis Descatha; Marcel Goldberg; Ellen Imbernon Journal: Scand J Work Environ Health Date: 2011-03-21 Impact factor: 5.024
Authors: Seth A Waits; Bradley N Reames; Robert W Krell; Benjamin Bryner; Terry Shih; Andrea T Obi; Peter K Henke; Rebecca M Minter; Michael J Englesbe; Sandra L Wong Journal: J Surg Educ Date: 2014 Mar-Apr Impact factor: 2.891
Authors: Cyriac Peters-Veluthamaningal; Daniëlle A W M van der Windt; Jan C Winters; Betty Meyboom-de Jong Journal: Cochrane Database Syst Rev Date: 2009-07-08
Authors: Julia Blackburn; Mark J W van der Oest; Ruud W Selles; Neal C Chen; Reinier Feitz; Ana-Maria Vranceanu; Jarry T Porsius Journal: Clin Orthop Relat Res Date: 2019-12 Impact factor: 4.176
Authors: Julia Blackburn; Mark J W van der Oest; Neal C Chen; Reinier Feitz; Liron S Duraku; J Michiel Zuidam; Ana-Maria Vranceanu; Ruud W Selles Journal: Clin Orthop Relat Res Date: 2021-05-01 Impact factor: 4.176